Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
1-Year Return 51.86%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+3.38%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$97B
AUM Growth
-$517M
Cap. Flow
-$311M
Cap. Flow %
-0.32%
Top 10 Hldgs %
37.18%
Holding
506
New
13
Increased
130
Reduced
158
Closed
20

Sector Composition

1 Consumer Discretionary 29%
2 Healthcare 24.31%
3 Technology 17.32%
4 Communication Services 11.22%
5 Financials 6.87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BLNK icon
426
Blink Charging
BLNK
$117M
$7K ﹤0.01%
396
+69
+21% +$1.22K
BMRN icon
427
BioMarin Pharmaceuticals
BMRN
$10.9B
$7K ﹤0.01%
82
EGHT icon
428
8x8 Inc
EGHT
$269M
$7K ﹤0.01%
2,045
NKE icon
429
Nike
NKE
$111B
$7K ﹤0.01%
90
WSM icon
430
Williams-Sonoma
WSM
$24.7B
$7K ﹤0.01%
126
NVRO
431
DELISTED
NEVRO CORP.
NVRO
$7K ﹤0.01%
154
ATEX icon
432
Anterix
ATEX
$417M
$6K ﹤0.01%
162
CSTL icon
433
Castle Biosciences
CSTL
$670M
$6K ﹤0.01%
225
DOMO icon
434
Domo
DOMO
$590M
$6K ﹤0.01%
321
FGEN icon
435
FibroGen
FGEN
$45.7M
$6K ﹤0.01%
19
FOLD icon
436
Amicus Therapeutics
FOLD
$2.47B
$6K ﹤0.01%
538
HI icon
437
Hillenbrand
HI
$1.82B
$6K ﹤0.01%
170
MATV icon
438
Mativ Holdings
MATV
$659M
$6K ﹤0.01%
265
MNTV
439
DELISTED
Momentive Global Inc. Common Stock
MNTV
$6K ﹤0.01%
1,095
SRNE
440
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$6K ﹤0.01%
3,711
-603
-14% -$975
AGIO icon
441
Agios Pharmaceuticals
AGIO
$2.1B
$5K ﹤0.01%
186
BLUE
442
DELISTED
bluebird bio
BLUE
$5K ﹤0.01%
43
CERS icon
443
Cerus
CERS
$255M
$5K ﹤0.01%
1,459
LBRDK icon
444
Liberty Broadband Class C
LBRDK
$8.53B
$5K ﹤0.01%
70
LSPD icon
445
Lightspeed Commerce
LSPD
$1.6B
$5K ﹤0.01%
310
OM icon
446
Outset Medical
OM
$237M
$5K ﹤0.01%
20
OXM icon
447
Oxford Industries
OXM
$636M
$5K ﹤0.01%
55
RARE icon
448
Ultragenyx Pharmaceutical
RARE
$3.01B
$5K ﹤0.01%
115
VUZI icon
449
Vuzix
VUZI
$171M
$5K ﹤0.01%
924
SUMO
450
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$5K ﹤0.01%
726